| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.29 | 0.03 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.27 | 0.03 |